ArticleTherapeutics and clinical risk management2017

Second-line afatinib administration in an elderly patient with squamous cell carcinoma.

Wolfgang Hohenforst-Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.